Our Goal is to make a Significant Impact on Metabolic Diseases
We are maximizing the potential of innovative molecules to make an impact on metabolic diseases, particularly in type 2 diabetes and are committed to developing new, safe and effective treatment options for patients suffering from type 2 diabetes and other metabolic disorders.
Why Our Focus is on Type 2 Diabetes
Type 2 diabetes is one of the world's major health concerns and its incidence is growing rapidly. It is the most common form of diabetes, affecting about 90% of diabetic patients.
The Challenge with the Current Standard of Care
The current standard of care for the majority of patients is limited by the fact that none of the available therapeutic options is satisfactorily effective in controlling the disease and marketed therapeutics are associated with safety and tolerability side effects as well as weight gain and hypoglycemia.